Millham LRI, Scott JA, Sax PE, Shebl FM, et al. Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States. J Acquir Immune Defic Syndr 2020;83:148-156.
PMID: 31929403